Binh Dinh Pharmaceutical and Medical Equipment JSC (HOSE: DBD)
Vietnam
· Delayed Price · Currency is VND
45,000
0.00 (0.00%)
At close: Oct 3, 2024
DBD Income Statement
Financials in millions VND. Fiscal year is January - December.
Millions VND. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
---|---|---|---|---|---|---|---|
Period Ending | Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
Revenue | 1,672,702 | 1,651,770 | 1,554,821 | 1,558,504 | 1,256,952 | 1,261,729 | Upgrade
|
Revenue Growth (YoY) | 1.07% | 6.24% | -0.24% | 23.99% | -0.38% | -9.94% | Upgrade
|
Cost of Revenue | 869,076 | 853,250 | 787,170 | 935,939 | 765,813 | 846,933 | Upgrade
|
Gross Profit | 803,626 | 798,520 | 767,652 | 622,566 | 491,139 | 414,796 | Upgrade
|
Selling, General & Admin | 509,744 | 501,538 | 494,312 | 405,437 | 309,356 | 254,046 | Upgrade
|
Operating Expenses | 509,744 | 501,538 | 494,312 | 405,437 | 309,356 | 254,046 | Upgrade
|
Operating Income | 293,882 | 296,982 | 273,339 | 217,129 | 181,783 | 160,750 | Upgrade
|
Interest Expense | -4,938 | -6,998 | -1,916 | -1,325 | -6,589 | -10,314 | Upgrade
|
Interest & Investment Income | 9,446 | 11,635 | 8,733 | 5,137 | 7,056 | 12,932 | Upgrade
|
Earnings From Equity Investments | 23,737 | 28,704 | 24,786 | 16,083 | 15,238 | 14,439 | Upgrade
|
Currency Exchange Gain (Loss) | -1,497 | -482.96 | 354.16 | 733.11 | -1,276 | -263.59 | Upgrade
|
Other Non Operating Income (Expenses) | -10,703 | -9,753 | -6,739 | -5,310 | -3,021 | -3,530 | Upgrade
|
EBT Excluding Unusual Items | 309,926 | 320,086 | 298,558 | 232,448 | 193,191 | 174,013 | Upgrade
|
Pretax Income | 309,926 | 320,086 | 298,558 | 232,448 | 193,191 | 174,013 | Upgrade
|
Income Tax Expense | 44,246 | 51,031 | 55,003 | 43,324 | 35,332 | 31,786 | Upgrade
|
Net Income | 265,680 | 269,055 | 243,555 | 189,124 | 157,860 | 142,227 | Upgrade
|
Preferred Dividends & Other Adjustments | 38,369 | 37,668 | 34,098 | 26,477 | 18,943 | 14,223 | Upgrade
|
Net Income to Common | 227,311 | 231,387 | 209,457 | 162,646 | 138,916 | 128,005 | Upgrade
|
Net Income Growth | -3.65% | 10.47% | 28.78% | 19.80% | 10.99% | -12.75% | Upgrade
|
Shares Outstanding (Basic) | 94 | 94 | 94 | 94 | 94 | 94 | Upgrade
|
Shares Outstanding (Diluted) | 94 | 94 | 94 | 94 | 94 | 94 | Upgrade
|
Shares Change (YoY) | 0.03% | - | - | -0.07% | -0.01% | - | Upgrade
|
EPS (Basic) | 2429.72 | 2473.29 | 2238.88 | 1738.52 | 1483.83 | 1367.17 | Upgrade
|
EPS (Diluted) | 2429.72 | 2473.29 | 2238.88 | 1738.52 | 1483.83 | 1367.17 | Upgrade
|
EPS Growth | 1.98% | 10.47% | 28.78% | 17.16% | 8.53% | -12.75% | Upgrade
|
Free Cash Flow | 157,875 | 160,298 | 82,184 | 62,932 | 153,173 | -150,664 | Upgrade
|
Free Cash Flow Per Share | 1687.53 | 1713.42 | 878.47 | 672.68 | 1636.12 | -1609.19 | Upgrade
|
Dividend Per Share | - | - | 1600.000 | - | 839.161 | 839.161 | Upgrade
|
Gross Margin | 48.04% | 48.34% | 49.37% | 39.95% | 39.07% | 32.88% | Upgrade
|
Operating Margin | 17.57% | 17.98% | 17.58% | 13.93% | 14.46% | 12.74% | Upgrade
|
Profit Margin | 13.59% | 14.01% | 13.47% | 10.44% | 11.05% | 10.15% | Upgrade
|
Free Cash Flow Margin | 9.44% | 9.70% | 5.29% | 4.04% | 12.19% | -11.94% | Upgrade
|
EBITDA | 336,949 | 340,193 | 315,005 | 255,818 | 213,592 | 188,695 | Upgrade
|
EBITDA Margin | 20.14% | 20.60% | 20.26% | 16.41% | 16.99% | 14.96% | Upgrade
|
D&A For EBITDA | 43,068 | 43,211 | 41,665 | 38,689 | 31,809 | 27,945 | Upgrade
|
EBIT | 293,882 | 296,982 | 273,339 | 217,129 | 181,783 | 160,750 | Upgrade
|
EBIT Margin | 17.57% | 17.98% | 17.58% | 13.93% | 14.46% | 12.74% | Upgrade
|
Effective Tax Rate | 14.28% | 15.94% | 18.42% | 18.64% | 18.29% | 18.27% | Upgrade
|
Revenue as Reported | 1,672,702 | 1,651,770 | 1,554,821 | 1,558,504 | 1,256,952 | 1,261,729 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.